中国民康医学
中國民康醫學
중국민강의학
MEDICAL JOURNAL OF CHINSEE PEOPLE HEALTH
2015年
9期
14-15,18
,共3页
刘萍%黄宗青%刘天亮%徐太磊
劉萍%黃宗青%劉天亮%徐太磊
류평%황종청%류천량%서태뢰
系统家庭治疗%精神分裂症%康复
繫統傢庭治療%精神分裂癥%康複
계통가정치료%정신분렬증%강복
Systemic family treatment%Schizophrenia%Rehabilitation
目的::探讨系统家庭治疗的精神分裂症患者远期疗效,为实施系统家庭治疗提供依据。方法:将95例精神分裂症患者随机分为治疗组(48例)和对照组(47例)。两组患者分别进行常规治疗护理加一般家庭随访,观察组患者在此基础上加用系统家庭治疗,患者出院后要求患者与家属定期接受复诊,尽量维持抗精神病药物种类与剂量不变,随访研究1年。于治疗前与治疗后6个月、12个月对两组患者进行简明精神病量表( BPRS)、社会功能缺陷筛选量表( SDSS)、自知力与治疗态度问卷( ITAQ)和Morningside康复量表( MRSS)评定,并观察1年后患者疾病的复发情况及服药依从性。结果:治疗1年后,治疗组患者各项指标分值明显低于对照组。结论:系统家庭治疗在精神康复治疗方面,不但能提高治疗依从性,控制疾病,改善自知力,而且还可以促进社会功能恢复,减少复发率。
目的::探討繫統傢庭治療的精神分裂癥患者遠期療效,為實施繫統傢庭治療提供依據。方法:將95例精神分裂癥患者隨機分為治療組(48例)和對照組(47例)。兩組患者分彆進行常規治療護理加一般傢庭隨訪,觀察組患者在此基礎上加用繫統傢庭治療,患者齣院後要求患者與傢屬定期接受複診,儘量維持抗精神病藥物種類與劑量不變,隨訪研究1年。于治療前與治療後6箇月、12箇月對兩組患者進行簡明精神病量錶( BPRS)、社會功能缺陷篩選量錶( SDSS)、自知力與治療態度問捲( ITAQ)和Morningside康複量錶( MRSS)評定,併觀察1年後患者疾病的複髮情況及服藥依從性。結果:治療1年後,治療組患者各項指標分值明顯低于對照組。結論:繫統傢庭治療在精神康複治療方麵,不但能提高治療依從性,控製疾病,改善自知力,而且還可以促進社會功能恢複,減少複髮率。
목적::탐토계통가정치료적정신분렬증환자원기료효,위실시계통가정치료제공의거。방법:장95례정신분렬증환자수궤분위치료조(48례)화대조조(47례)。량조환자분별진행상규치료호리가일반가정수방,관찰조환자재차기출상가용계통가정치료,환자출원후요구환자여가속정기접수복진,진량유지항정신병약물충류여제량불변,수방연구1년。우치료전여치료후6개월、12개월대량조환자진행간명정신병량표( BPRS)、사회공능결함사선량표( SDSS)、자지력여치료태도문권( ITAQ)화Morningside강복량표( MRSS)평정,병관찰1년후환자질병적복발정황급복약의종성。결과:치료1년후,치료조환자각항지표분치명현저우대조조。결론:계통가정치료재정신강복치료방면,불단능제고치료의종성,공제질병,개선자지력,이차환가이촉진사회공능회복,감소복발솔。
Objective:To provide a basis of systemic family treatment ( SFT) by evaluating the long term curative effect of SFT for the schizophrenics. Methods: 95 patients with schizophrenia were randomly divided into treatment group ( n=48 ) and control group (n=47). All the patients were treated by conventional therapy, nursing and home follow-up, while the cases in treatment group were provided with SFT additionally. All the patients and their family members were asked to have subsequently visit regularly for one year and have the same kind and dosage of the medicine. The brief psychiatric rating scale ( BPRS) , social disability screening sched-ule (SDSS), insight and treatment attitude questionnaire (ITAQ) and Morningside rehabilitation status scale (MRSS) were used to assess before and 6 and 12 months after the treatment. Moreover, the recurrence and medication compliance were observed 1 year after the treatment. Results:1 year after the treatment. , all the scales of treatment group were lower than those of control group. Conclu-sions:In the treatment of schizophrenia, systemic family treatment can improve the treatment compliance, prevent the development the of disease, enhance the insight as well as the social function, and reduce the relapse of schizophrenia.